Tobacco company Philip Morris International (PMI) is raising eyebrows as it edges ever closer to its acquisition of UK inhaler maker Vectura and investment experts are divided about the future of the company from an ESG perspective.
"If one was cynical, one could say this is a move to greenwash over the less desirable areas of the business," said Miranda Beacham, head of ESG for equities & multi asset at Aegon AM. Whether one is cynical or not, when considering the big picture, Chris Beckett, equity analyst at Quilter Cheviot, said the deal "does not change very much". It is quite small in comparison to the overall company, at around $1bn, while Philip Morris' market cap is around $156bn. ESG assets on track to exceed $50trn by 2025 However, Beckett added that "where it does make a difference is the intenti...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
